Jeffrey W. Albers is of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2024, when has been sold 5,000 shares (Common Stock) at a price of $49.1 per share, resulting in proceeds of $245,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Jeffrey W. Albers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2024
SELL
Open market or private sale
$245,500 $49.1 p/Share
5,000 Reduced 100.0%
0 Common Stock
Aug 26 2024
BUY
Exercise of conversion of derivative security
$51,700 $10.34 p/Share
5,000 Added 50.0%
5,000 Common Stock
Feb 21 2024
SELL
Open market or private sale
$171,234 $39.05 p/Share
4,385 Reduced 100.0%
0 Common Stock
Feb 21 2024
BUY
Exercise of conversion of derivative security
$45,340 $10.34 p/Share
4,385 Added 50.0%
4,385 Common Stock
Feb 20 2024
SELL
Open market or private sale
$24,028 $39.07 p/Share
615 Reduced 100.0%
0 Common Stock
Feb 20 2024
BUY
Exercise of conversion of derivative security
$6,359 $10.34 p/Share
615 Added 50.0%
615 Common Stock
Jan 23 2024
SELL
Open market or private sale
$300,500 $30.05 p/Share
10,000 Reduced 100.0%
0 Common Stock
Jan 23 2024
BUY
Exercise of conversion of derivative security
$103,400 $10.34 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

BPMC
Blueprint Medicines Corp Healthcare
MGTA
Magenta Therapeutics, Inc. Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
JWA

Jeffrey W. Albers

Cambridge, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR